Stay updated on Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0. This is a site-level update rather than a change to the clinical trial record.SummaryDifference0.1%

- Check12 days agoChange DetectedA site-wide notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It does not alter the study record.SummaryDifference0.7%

- Check19 days agoChange DetectedThe site footer’s displayed revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study history now includes a new revision entry 'Revision: v3.7.0' added and the previous 'Revision: v3.6.6' entry removed. This indicates a version update to the study record in the history.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry (v3.6.6) is added to the Study Record Versions, and the previous revision (v3.6.5) is removed, updating the historical record.SummaryDifference0.1%

Stay in the know with updates to Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.